FONT-SIZE Plus   Neg

Conn's Prices Public Offering Of 5.50 Mln Shares At $26.75 Per Share

Conn's Inc. (CONN) announced the pricing of its public offering of 5.50 million shares of its common stock at a price to the public of $26.75 per share. Of the 5.50 million shares of common stock being offered, the company is offering 1.41 million shares and the selling stockholders are offering 4.09 million shares.

The company noted that it has also granted the underwriters a 30-day option to purchase up to an additional 825,000 shares to cover over-allotments, if any. The offering size was increased from 5 million shares to 5.50 million shares at pricing. The additional 500,000 shares are being offered by the selling stockholders. The offering is expected to close on or around December 12, 2012, subject to customary closing conditions.

The company stated that it expects to receive net proceeds from the offering of approximately $35.2 million, after deducting estimated underwriting discounts and commissions and offering expenses.

The company added that it intends to use the net proceeds from the offering primarily for the repayment of debt under the Company's asset-based loan facility and to pay for the fees and expenses that the company incurred in connection with the offering.

The company will not receive any proceeds from the sale of shares of common stock offered by the selling stockholders in the offering.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Trade CONN now with 
Follow RTT